Drugs / Victorhy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06645509 | Apr 2024 → Jun 2025 | hyperhidrosis palmaris ET plantaris | Dryox Health | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Victorhy | “Victorhy” NCT06645509 ↗ |
| Known as | TTB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06645509 ↗ |
| Route | Topical | “A topical administration of Victorhy (TTB gel) to both hands, once daily for 28 days” NCT06645509 ↗ |